Novel glucagon analogues

Details for Australian Patent Application No. 2011231503 (hide)

Owner Novo Nordisk A/S

Inventors Lau, Jesper F.; Kruse, Thomas; Linderoth, Lars; Thogersen, Henning

Agent Shelston IP

Pub. Number AU-A-2011231503

PCT Pub. Number WO2011/117416

Priority 61/319,994 01.04.10 US; 10157901.9 26.03.10 EP

Filing date 28 March 2011

Wipo publication date 29 September 2011

International Classifications

C07K 14/605 Peptides having more than 20 amino acids

A61K 38/26 Medicinal preparations containing peptides - Glucagons

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/117416 Priority application(s): WO2011/117416

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011231508-Tricyclic indole derivatives as PBR ligands

2011231491-Method for coating a core of an arbitrary shape by thermoforming, automatic machine for the implementation thereof and finished product obtained by such a method